Status:
COMPLETED
A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients
Lead Sponsor:
Ain Shams University
Conditions:
Antioxidative Stress
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
An Open labeled, Paralled, Randomized, Prospective, study was conducted on 60 patients who were randomized into 3 groups, 22, 20 and 18 patients in Control, Selenium and, Thiotacid groups respectively...
Eligibility Criteria
Inclusion
- prevalent hemodialysis patients
Exclusion
- Patients with Inflammatory diseases, hepatic or respiratory diseases, smokers and alcoholics, were excluded from the study.
Key Trial Info
Start Date :
January 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2019
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05266794
Start Date
January 22 2019
End Date
April 30 2019
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11566